相关实验视频
Updated: May 2, 2026

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
24.4K
卡布基心脏病患者:心脏手术后的结果
Regina W Lam1, Victoria Haro2, Sarah Tabbutt2,3
1Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.
Cardiology in the young
|February 26, 2025
概括
接受新生儿心脏手术的卡布基综合征患者的生存率较低,并发症风险更高. 尽管面临挑战,但有些人活到幼儿时代,这表明可能在没有呼吸机支持的情况下出院.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 生产性心脏手术 手术 生产心脏手术
- 遗传学 是一个遗传学.
背景情况:
- 卡布基综合征是一种罕见的遗传疾病,通常与先天性心脏缺陷有关.
- 这些患者的新生儿先天性心脏手术带来了独特的挑战.
研究的目的:
- 评估新生儿先天性心脏手术后卡布基综合征患者的手术结果.
- 为了将生存率和发病率与非卡布基基因异常患者进行比较.
主要方法:
- 单中心回顾性研究 (2018-2023年).
- 审查了接受新生儿先天性心脏手术的七名卡布基综合征患者.
- 与非卡布基基因异常的新生儿比较结果 (生存率,发病率,停留时间).
主要成果:
- 卡布基综合征患者的住院生存率为71%,对照组为88%.
- 卡布基综合征患者的非计划性干预率 (43%),脑部异常成像 (29%) 和细菌血症 (29%) 较高.
- 在卡布基综合征患者中,观察到更长的中位数呼吸器日 (16 vs 6) 和住院时间 (66 vs 41 天).
结论:
- 卡布基综合征患者单心室生理学面临显著的死亡率和心脏手术后的发病率风险.
- 存活到出院是可能的,一些患者实现了呼吸机独立,并存活到幼儿年龄.
更多相关视频
相关概念视频
Cardiac Catheterization I: Pre-Procedure Overview
3.4K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.4K
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Cardiomyopathy VII: Pre and Post Operative Nursing Management
460
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
460

